143 related articles for article (PubMed ID: 25425197)
21. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Baldoni S; Del Papa B; Dorillo E; Aureli P; De Falco F; Rompietti C; Sorcini D; Varasano E; Cecchini D; Zei T; Di Tommaso A; Rosati E; Alexe G; Roti G; Stegmaier K; Di Ianni M; Falzetti F; Sportoletti P
Int J Cancer; 2018 Aug; 143(4):958-970. PubMed ID: 29508386
[TBL] [Abstract][Full Text] [Related]
22. IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
Wang WC; Kuo CY; Tzang BS; Chen HM; Kao SH
J Cell Biochem; 2012 Nov; 113(11):3567-75. PubMed ID: 22740511
[TBL] [Abstract][Full Text] [Related]
23. Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.
Riches JC; O'Donovan CJ; Kingdon SJ; McClanahan F; Clear AJ; Neuberg DS; Werner L; Croce CM; Ramsay AG; Rassenti LZ; Kipps TJ; Gribben JG
Blood; 2014 Jun; 123(26):4101-10. PubMed ID: 24829201
[TBL] [Abstract][Full Text] [Related]
24. Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
Sutton LA; Ljungström V; Mansouri L; Young E; Cortese D; Navrkalova V; Malcikova J; Muggen AF; Trbusek M; Panagiotidis P; Davi F; Belessi C; Langerak AW; Ghia P; Pospisilova S; Stamatopoulos K; Rosenquist R
Haematologica; 2015 Mar; 100(3):370-6. PubMed ID: 25480502
[TBL] [Abstract][Full Text] [Related]
25. MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia.
Wu B; Słabicki M; Sellner L; Dietrich S; Liu X; Jethwa A; Hüllein J; Walther T; Wagner L; Huang Z; Zapatka M; Zenz T
Br J Haematol; 2017 Nov; 179(3):421-429. PubMed ID: 28771672
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}.
Barragán M; de Frias M; Iglesias-Serret D; Campàs C; Castaño E; Santidrián AF; Coll-Mulet L; Cosialls AM; Domingo A; Pons G; Gil J
J Leukoc Biol; 2006 Dec; 80(6):1473-9. PubMed ID: 16940331
[TBL] [Abstract][Full Text] [Related]
27. The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival.
Barata JT
Adv Enzyme Regul; 2011; 51(1):37-49. PubMed ID: 21035501
[TBL] [Abstract][Full Text] [Related]
28. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells.
Joshi MB; Ivanov D; Philippova M; Erne P; Resink TJ
FASEB J; 2007 Oct; 21(12):3083-95. PubMed ID: 17485554
[TBL] [Abstract][Full Text] [Related]
29. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
30. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal regulation of Notch and PI3K/Akt signalling in T-ALL cells in vitro.
Calzavara E; Chiaramonte R; Cesana D; Basile A; Sherbet GV; Comi P
J Cell Biochem; 2008 Apr; 103(5):1405-12. PubMed ID: 17849443
[TBL] [Abstract][Full Text] [Related]
32. NOTCH1 intracellular domain negatively regulates PAK1 signaling pathway through direct interaction.
Yoon JH; Mo JS; Ann EJ; Ahn JS; Jo EH; Lee HJ; Hong SH; Kim MY; Kim EG; Lee K; Park HS
Biochim Biophys Acta; 2016 Feb; 1863(2):179-88. PubMed ID: 26547035
[TBL] [Abstract][Full Text] [Related]
33. Glycogen synthase kinase 3-β phosphorylates novel S/T-P-S/T domains in Notch1 intracellular domain and induces its nuclear localization.
Han X; Ju JH; Shin I
Biochem Biophys Res Commun; 2012 Jun; 423(2):282-8. PubMed ID: 22640738
[TBL] [Abstract][Full Text] [Related]
34. Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of
Cavallini C; Visco C; Putta S; Rossi D; Mimiola E; Purvis N; Lovato O; Perbellini O; Falisi E; Facco M; Trentin L; Romanelli MG; Semenzato G; Ambrosetti A; Gaidano G; Pizzolo G; Cesano A; Scupoli MT
Haematologica; 2017 Apr; 102(4):e144-e147. PubMed ID: 27927769
[No Abstract] [Full Text] [Related]
35. Akt activation through the phosphorylation of erythropoietin receptor at tyrosine 479 is required for myeloproliferative disorder-associated JAK2 V617F mutant-induced cellular transformation.
Kamishimoto J; Tago K; Kasahara T; Funakoshi-Tago M
Cell Signal; 2011 May; 23(5):849-56. PubMed ID: 21255641
[TBL] [Abstract][Full Text] [Related]
36. LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
Kristensen L; Kristensen T; Abildgaard N; Royo C; Frederiksen M; Mourits-Andersen T; Campo E; Møller MB
Eur J Haematol; 2016 Aug; 97(2):175-82. PubMed ID: 26558352
[TBL] [Abstract][Full Text] [Related]
37. GSK-3 signaling in health.
McCubrey JA; Cocco L
Adv Biol Regul; 2017 Aug; 65():1-4. PubMed ID: 28705437
[No Abstract] [Full Text] [Related]
38. Phosphatidylinositol 3-kinase/Akt plays a role in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts.
Takai S; Tokuda H; Matsushima-Nishiwaki R; Hanai Y; Kato K; Kozawa O
J Cell Biochem; 2006 Aug; 98(5):1249-56. PubMed ID: 16514645
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of IL-1beta in Fanconi anaemia group A patients due to a constitutively active phosphoinositide 3-kinase-Akt pathway are capable of promoting tumour cell proliferation.
Ibáñez A; Río P; Casado JA; Bueren JA; Fernández-Luna JL; Pipaón C
Biochem J; 2009 Jul; 422(1):161-70. PubMed ID: 19473116
[TBL] [Abstract][Full Text] [Related]
40. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation.
Di Ianni M; Baldoni S; Rosati E; Ciurnelli R; Cavalli L; Martelli MF; Marconi P; Screpanti I; Falzetti F
Br J Haematol; 2009 Sep; 146(6):689-91. PubMed ID: 19604236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
